Pemetrexed or Docetaxel With or Without Erlotinib in Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Afshin Dowlati, MD
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Wayne State University
Detroit, Michigan, United States
- Columbia Presbyterian
New York, New York, United States
- Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Cleveland, Ohio, United States
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Cleveland, Ohio, United States
- Lake/university Ireland Cancer Center
Cleveland, Ohio, United States
- Metrohealth Medical Center
Cleveland, Ohio, United States
- Southwest General Health Center
Cleveland, Ohio, United States
- Uhhs Chagrin Highlands Medical Center
Cleveland, Ohio, United States
- Uhhs Westlake Medical Center
Cleveland, Ohio, United States
- Ohio State University
Columbus, Ohio, United States
- Riverside Methodist Hospital
Columbus, Ohio, United States
- Uh-Monarch
Mayfield Heights, Ohio, United States
- Uh-Firelands
Sandusky, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2008
- Primary completion
- 30 Apr 2013
- Completion
- 31 Jul 2015
- Last update posted
- 12 Oct 2015
- Registered enrollment
- 46
- Registry id
- NCT00660816
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.